Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 293661 - 293680 out of 495964 entries
| Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
|---|---|---|---|---|---|---|---|---|
| Latvia | (L01EC01) vemurafenib (adm: O) | Zelboraf 240mg Nr.56 (4 oriģ.) + Cotellic 20mg Nr.63 (1 oriģ.) | 1 kompl. apvalkotas tabletes, 240mg + 20mg | Retail price with vat |
$0-0 |
$0-0 |
n/a | RocheLatvijaSIA;RocheRegistrationGmbH |
| Latvia | (L01ED03) alectinib (adm: O) | Alecensa | 224 cietas kapsulas, 150 | Retail price with vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung | RocheLatvijaSIA;RocheRegistrationGmbH / RochePharmaAG,Germany |
| Latvia | (L01ED04) brigatinib (adm: O) | Alunbrig | 28 apvalkotas tabletes, 180 | Retail price with vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung | TakedaPharmaA/S;TakedaManufacturingAustriaAG;TakedaPharmaceuticalsInternationalAGIreland / TakedaAustriaGmbH,Austria;TakedaIrelandLimited,Ireland |
| Latvia | (L01ED04) brigatinib (adm: O) | Alunbrig | 28 apvalkotas tabletes, 30 | Retail price with vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung | TakedaPharmaA/S;TakedaManufacturingAustriaAG;TakedaPharmaceuticalsInternationalAGIreland / TakedaAustriaGmbH,Austria;TakedaIrelandLimited,Ireland |
| Latvia | (L01ED04) brigatinib (adm: O) | Alunbrig | 28 apvalkotas tabletes, 90 | Retail price with vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung | TakedaPharmaA/S;TakedaManufacturingAustriaAG;TakedaPharmaceuticalsInternationalAGIreland / TakedaAustriaGmbH,Austria;TakedaIrelandLimited,Ireland |
| Latvia | (L01ED05) lorlatinib (adm: O) | Lorviqua | 30 apvalkotas tabletes, 100 | Retail price with vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung | PfizerEuropeMAEEIG / PfizerManufacturingDeutschlandGmbH,Germany |
| Latvia | (L01ED05) lorlatinib (adm: O) | Lorviqua | 90 apvalkotas tabletes, 25 | Retail price with vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung | PfizerEuropeMAEEIG / PfizerManufacturingDeutschlandGmbH,Germany |
| Latvia | (L01EF01) palbociclib (adm: O) | Ibrance | 21 apvalkotas tabletes, 100 | Retail price with vat |
$0-0 |
$0-0 |
Breast Neoplasms | PfizerEuropeMAEEIG / PfizerManufacturingDeutschlandGmbH,Germany |
| Latvia | (L01EF01) palbociclib (adm: O) | Ibrance | 21 apvalkotas tabletes, 125 | Retail price with vat |
$0-0 |
$0-0 |
Breast Neoplasms | PfizerEuropeMAEEIG / PfizerManufacturingDeutschlandGmbH,Germany |
| Latvia | (L01EF01) palbociclib (adm: O) | Ibrance | 21 apvalkotas tabletes, 75 | Retail price with vat |
$0-0 |
$0-0 |
Breast Neoplasms | PfizerEuropeMAEEIG / PfizerManufacturingDeutschlandGmbH,Germany |
| Latvia | (L01EF03) abemaciclib (adm: O) | Verzenios | 42 apvalkotas tabletes, 100 | Retail price with vat |
$0-0 |
$0-0 |
Breast Neoplasms | EliLillyNederlandB.V. / LillyS.A.,Spain |
| Latvia | (L01EF03) abemaciclib (adm: O) | Verzenios | 42 apvalkotas tabletes, 150 | Retail price with vat |
$0-0 |
$0-0 |
Breast Neoplasms | EliLillyNederlandB.V. / LillyS.A.,Spain |
| Latvia | (L01EF03) abemaciclib (adm: O) | Verzenios | 42 apvalkotas tabletes, 50 | Retail price with vat |
$0-0 |
$0-0 |
Breast Neoplasms | EliLillyNederlandB.V. / LillyS.A.,Spain |
| Latvia | (L01EG02) everolimus (adm: O) | Everolimus Norameda 5mg | 30 tabletes, 5 | Retail price with vat |
$0-0 |
$0-0 |
n/a | NoramedaUAB / SynthonBV,Netherlands;SynthonHispaniaS.L.,Spain |
| Latvia | (L01EK01) axitinib (adm: O) | Inlyta | 56 apvalkotas tabletes, 1 | Retail price with vat |
$0-0 |
$0-0 |
Carcinoma, Renal Cell | PfizerEuropeMAEEIG / PfizerManufacturingDeutschlandGmbH,Germany |
| Latvia | (L01EK01) axitinib (adm: O) | Inlyta | 56 apvalkotas tabletes, 5 | Retail price with vat |
$0-0 |
$0-0 |
Carcinoma, Renal Cell | PfizerEuropeMAEEIG / PfizerManufacturingDeutschlandGmbH,Germany |
| Latvia | (L01EL01) ibrutinib (adm: O) | Imbruvica | 30 apvalkotas tabletes, 140 | Retail price with vat |
$0-0 |
$0-0 |
Lymphoma, Mantle-Cell;Leukemia, Lymphocytic, Chronic, B-Cell | Janssen-CilagInternationalNV / JanssenCilagS.p.A.,Italy |
| Latvia | (L01EL01) ibrutinib (adm: O) | Imbruvica | 30 apvalkotas tabletes, 420 | Retail price with vat |
$0-0 |
$0-0 |
Lymphoma, Mantle-Cell;Leukemia, Lymphocytic, Chronic, B-Cell | Janssen-CilagInternationalNV / JanssenCilagS.p.A.,Italy |
| Latvia | (L01EL01) ibrutinib (adm: O) | Imbruvica | 30 apvalkotas tabletes, 560 | Retail price with vat |
$0-0 |
$0-0 |
Lymphoma, Mantle-Cell;Leukemia, Lymphocytic, Chronic, B-Cell | Janssen-CilagInternationalNV / JanssenCilagS.p.A.,Italy |
| Latvia | (L01EL02) acalabrutinib (adm: O) | Calquence | 60 apvalkotas tabletes, 100 | Retail price with vat |
$0-0 |
$0-0 |
Leukemia, Lymphocytic, Chronic, B-Cell | AstraZenecaAB / AstraZenecaAB,Sweden |
Pages
